• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[勘误] H19/微小RNA-675轴在人皮肤鳞状细胞癌细胞增殖和上皮-间质转化中的作用

[Corrigendum] Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.

作者信息

Zhang Wenqing, Zhou Kaili, Zhang Xue, Wu Chenglong, Deng Dan, Yao Zhirong

机构信息

Department of Dermatology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, P.R. China.

出版信息

Oncol Rep. 2023 Aug;50(2). doi: 10.3892/or.2023.8586. Epub 2023 Jun 16.

DOI:10.3892/or.2023.8586
PMID:37326099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10308453/
Abstract

Following the publication of the above paper, a concerned reader drew to the authors' attention that, in Fig. 4C on p. 8, the 'Invasion, miR‑675‑inhibitor' data panel appeared to contain an overlapping section with the 'Invasion, mi‑R675‑inhibitor + pcDNA3.1‑H19' data panel for the SCL1 cell line, such that the data were likely to have been derived from the same original source, even though they were intended to show the results from differently performed experiments. After having examined the original data, the authors also realized that the 'Inhibitor‑NC' and 'miR‑675‑inhibitor' data panels showing the migration assay experiments for the A431 cell line in the same figure part had also inadvertently been derived from the same original source. After having been granted permission from the Editor of to repeat the experiments shown in Fig. 4C, the revised version of Fig. 4, incorporating the new data for Fig. 4C, is shown on the next page. Note that these errors did not affect the overall conclusions reported in the study, and the repeated experiment yielded similar results to those obtained originally. The authors are grateful to the Editor for allowing them the opportunity to publish this corrigendum, and all the authors agree with the publication of this; furthermore, they apologize for any inconvenience caused to the readership of the Journal. [Oncology Reports 45: 39, 2021; DOI: 10.3892/or.2021.7990].

摘要

上述论文发表后,一位关注此事的读者提请作者注意,在第8页的图4C中,SCL1细胞系的“侵袭,miR‑675抑制剂”数据面板似乎与“侵袭,miR‑675抑制剂 + pcDNA3.1‑H19”数据面板存在重叠部分,以至于这些数据可能源自同一原始来源,尽管它们旨在展示不同实验的结果。在检查原始数据后,作者还意识到,同一图部分中显示A431细胞系迁移实验的“抑制剂‑NC”和“miR‑675抑制剂”数据面板也无意中源自同一原始来源。在获得《肿瘤学报告》编辑的许可后,重复了图4C中所示的实验,包含图4C新数据的图4修订版见下一页。请注意,这些错误并未影响该研究报告的总体结论,重复实验得到的结果与最初获得的结果相似。作者感谢编辑给予他们发表这份勘误的机会,所有作者均同意发表此勘误;此外,他们对给《肿瘤学报告》读者带来的不便表示歉意。[《肿瘤学报告》45: 39, 2021;DOI: 10.3892/or.2021.7990]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ec/10308453/52aec208f964/or-50-02-08586-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ec/10308453/52aec208f964/or-50-02-08586-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ec/10308453/52aec208f964/or-50-02-08586-g00.jpg

相似文献

1
[Corrigendum] Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.[勘误] H19/微小RNA-675轴在人皮肤鳞状细胞癌细胞增殖和上皮-间质转化中的作用
Oncol Rep. 2023 Aug;50(2). doi: 10.3892/or.2023.8586. Epub 2023 Jun 16.
2
[Corrigedum] miR‑185 inhibits non‑small cell lung cancer cell proliferation and invasion through targeting of SOX9 and regulation of Wnt signaling.[勘误] miR-185通过靶向SOX9和调节Wnt信号通路抑制非小细胞肺癌细胞的增殖和侵袭。
Mol Med Rep. 2023 May;27(5). doi: 10.3892/mmr.2023.12984. Epub 2023 Mar 24.
3
[Corrigendum] Identification of lncRNA EGOT as a tumor suppressor in renal cell carcinoma.[勘误] 长链非编码RNA EGOT作为肾细胞癌肿瘤抑制因子的鉴定
Mol Med Rep. 2024 May;29(5). doi: 10.3892/mmr.2024.13194. Epub 2024 Mar 8.
4
[Corrigendum] Long non‑coding RNA H19 regulates LASP1 expression in osteosarcoma by competitively binding to miR‑29a‑3p.[勘误] 长链非编码RNA H19通过竞争性结合miR-29a-3p调控骨肉瘤中LASP1的表达。
Oncol Rep. 2024 Jun;51(6). doi: 10.3892/or.2024.8737. Epub 2024 Apr 19.
5
[Corrigendum] Nogo‑B promotes the epithelial‑mesenchymal transition in HeLa cervical cancer cells via Fibulin‑5.[勘误] Nogo-B通过Fibulin-5促进人宫颈癌HeLa细胞上皮-间质转化
Oncol Rep. 2022 May;47(5). doi: 10.3892/or.2022.8311. Epub 2022 Mar 29.
6
[Corrigendum] STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway.[勘误] STMN1 是食管鳞癌的预后预测因子,是 PI3K 通路激活的标志物。
Oncol Rep. 2021 Jan;45(1):401-402. doi: 10.3892/or.2020.7855. Epub 2020 Nov 13.
7
[Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression.[勘误] miR-195通过下调PRR11表达抑制人前列腺癌细胞增殖和血管生成。
Oncol Rep. 2023 Apr;49(4). doi: 10.3892/or.2023.8507. Epub 2023 Feb 24.
8
[Corrigendum] miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression.[勘误] miR-23a通过抑制PLK-1表达抑制胰腺癌细胞进展。
Mol Med Rep. 2022 Jul;26(1). doi: 10.3892/mmr.2022.12738. Epub 2022 May 18.
9
[Corrigendum] Repression of Smad4 by miR‑205 moderates TGF‑β-induced epithelial‑mesenchymal transition in A549 cell lines.[勘误] miR-205 对 Smad4 的抑制作用调节了 A549 细胞系中 TGF-β诱导的上皮-间充质转化。
Int J Oncol. 2021 Feb;58(2):276-277. doi: 10.3892/ijo.2021.5166. Epub 2021 Jan 4.
10
[Corrigendum] microRNA‑181a‑5p functions as an oncogene in renal cell carcinoma.[勘误] 微小RNA-181a-5p在肾细胞癌中起癌基因作用。
Mol Med Rep. 2024 Apr;29(4). doi: 10.3892/mmr.2024.13182. Epub 2024 Feb 16.

引用本文的文献

1
Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway.长链非编码RNA ABHD11-AS1通过与表皮生长因子受体(EGFR)相互作用抑制EGFR/ERK信号通路,从而抑制结直肠癌进展。
Int J Oncol. 2025 Mar;66(3). doi: 10.3892/ijo.2025.5726. Epub 2025 Feb 14.